New pill tested for millions with stubborn arthritis
NCT ID NCT07452445
Summary
This study is testing a new oral medication called ivarmacitinib for people with moderate-to-severe rheumatoid arthritis (RA) who haven't gotten enough relief from common first-line drugs like methotrexate. It aims to see if this pill can better control the disease and reduce symptoms like joint pain and swelling. The trial will also closely monitor the drug's safety in about 100 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.